Kestra Advisory Services’s NeoGenomics NEO Stock Holding History

Kestra Advisory Services’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,311	Closed	-$38.9K	–	3944
2025 Q4	$38.9K	Buy	+3,311	New	+$35.7K	﹤0.01%	4113
2024 Q2	–	Sell	-31,520	Closed	-$495K	–	2660
2024 Q1	$495K	Sell	31,520 -2,725	-8%	-$42.1K	﹤0.01%	1674
2023 Q4	$554K	Sell	34,245 -26,300	-43%	-$430K	﹤0.01%	1462
2023 Q3	$745K	Buy	60,545 +43,750	+260%	+$651K	0.01%	1150
2023 Q2	$270K	Buy	+16,795	New	+$277K	﹤0.01%	1696
2021 Q4	–	Sell	-5,550	Closed	-$268K	–	2134
2021 Q3	$268K	Buy	5,550 +254	+5%	+$11.8K	﹤0.01%	1768
2021 Q2	$239K	Sell	5,296 -1,952	-27%	-$86.5K	﹤0.01%	1735
2021 Q1	$350K	Buy	7,248 +123	+2%	+$6.4K	﹤0.01%	1369
2020 Q4	$386K	Buy	+7,125	New	+$322K	﹤0.01%	1339

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Kestra Advisory Services's NEO Position: Q1 2026 in Review

Kestra Advisory Services sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 3,311 shares — an estimated $38.9K sold.

Kestra Advisory Services first reported a position in NEO in Q4 2020 and held it in 9 quarters. The position peaked at $745K in Q3 2023. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

Kestra Advisory Services reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
Kestra Advisory Services sold 3,311 NeoGenomics shares in Q1 2026, an estimated $38.9K.
Kestra Advisory Services first reported a position in NeoGenomics in Q4 2020 and held it in 9 quarters.
Kestra Advisory Services's NeoGenomics position peaked at $745K in Q3 2023.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.